$SCPX
Scorpius Holdings, Inc. Stock $scpx

$scpx Overview Financials Valuation SEC Filings Company Website

2014 Q2 Form 10-Q Financial Statement

#000155335014000502 Filed on May 12, 2014

Income Statement

Concept	2014 Q2	2014 Q1	2013 Q1
Revenue	$6.546K
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.010M	$1.010M	$270.0K
YoY Change	129.55%	274.07%	17.39%
% of Gross Profit
Research & Development	$849.4K	$533.6K	$440.3K
YoY Change	23.28%	21.2%	158.99%
% of Gross Profit
Depreciation & Amortization	$18.90K	$2.170K	$814.00
YoY Change	14436.92%	166.58%
% of Gross Profit
Operating Expenses	$2.977M	$2.395M	$770.5K
YoY Change	88.2%	210.83%	75.11%
Operating Profit	-$2.977M	-$2.395M	-$770.5K
YoY Change	88.2%	210.83%
Interest Expense			$28.34K
YoY Change
% of Operating Profit
Other Income/Expense, Net	$19.08K	-$28.08K	-$17.98K
YoY Change	-120.71%	56.2%
Pretax Income	-$2.960M	-$2.420M	-$790.0K
YoY Change	77.25%	206.33%	75.56%
Income Tax	$0.00		$0.00
% Of Pretax Income
Net Earnings	-$2.847M	-$2.331M	-$3.064M
YoY Change	75.65%	-23.93%	596.33%
Net Earnings / Revenue	-43490.91%
Basic Earnings Per Share
Diluted Earnings Per Share	-$31.66	-$25.88	-$102.00
COMMON SHARES
Basic Shares Outstanding	6.452M shares	6.452M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2014 Q2	2014 Q1	2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$16.80M	$19.40M	$4.900M
YoY Change	460.0%	295.92%
Cash & Equivalents	$5.983M	$2.690M	$4.890M
Short-Term Investments	$10.90M	$16.70M
Other Short-Term Assets	$700.0K	$900.0K	$200.0K
YoY Change	40.0%	350.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$17.55M	$20.33M	$5.100M
YoY Change	396.89%	298.68%
LONG-TERM ASSETS
Property, Plant & Equipment	$480.9K	$56.74K	$0.00
YoY Change	4788.38%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$21.05K	$10.57K	$100.0K
YoY Change	-78.95%	-89.43%
Total Long-Term Assets	$502.0K	$67.31K	$100.0K
YoY Change	732.8%	-32.69%
TOTAL ASSETS
Total Short-Term Assets	$17.55M	$20.33M	$5.100M
Total Long-Term Assets	$502.0K	$67.31K	$100.0K
Total Assets	$18.05M	$20.40M	$5.200M
YoY Change	401.15%	292.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$720.1K	$378.4K	$1.100M
YoY Change	-45.4%	-65.6%
Accrued Expenses	$320.1K	$378.5K	$0.00
YoY Change	51.25%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due			$300.0K
YoY Change
Total Short-Term Liabilities	$1.040M	$756.9K	$1.400M
YoY Change	-39.67%	-45.94%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$1.100M
YoY Change	-100.0%	-100.0%
Other Long-Term Liabilities			$100.0K
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$1.200M
YoY Change	-100.0%	-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.040M	$756.9K	$1.400M
Total Long-Term Liabilities	$0.00	$0.00	$1.200M
Total Liabilities	$1.040M	$756.9K	$2.400M
YoY Change	-58.26%	-68.46%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$975.00	$975.00
YoY Change	140.74%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$17.49M	$20.01M	$2.700M
YoY Change
Total Liabilities & Shareholders Equity	$18.05M	$20.40M	$5.200M
YoY Change	401.15%	292.31%

Cashflow Statement

Concept	2014 Q2	2014 Q1	2013 Q1
OPERATING ACTIVITIES
Net Income	-$2.847M	-$2.331M	-$3.064M
YoY Change	75.65%	-23.93%	596.33%
Depreciation, Depletion And Amortization	$18.90K	$2.170K	$814.00
YoY Change	14436.92%	166.58%
Cash From Operating Activities	-$2.110M	-$2.391M	-$504.1K
YoY Change	51.8%	374.33%	14.56%
INVESTING ACTIVITIES
Capital Expenditures	$440.0K	$5.155K
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$5.850M	$480.0K	$0.00
YoY Change
Cash From Investing Activities	$5.400M	$477.5K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00	$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	$36.73K	$5.389M
YoY Change	-100.0%	-99.32%	1281.74%
NET CHANGE
Cash From Operating Activities	-2.110M	-$2.391M	-$504.1K
Cash From Investing Activities	5.400M	$477.5K
Cash From Financing Activities	0.000	$36.73K	$5.389M
Net Change In Cash	3.290M	-$1.877M	$4.885M
YoY Change	-275.0%	-138.42%	-9869.39%
FREE CASH FLOW
Cash From Operating Activities	-$2.110M	-$2.391M	-$504.1K
Capital Expenditures	$440.0K	$5.155K
Free Cash Flow	-$2.550M	-$2.396M	-$504.1K
YoY Change	83.45%	375.35%	14.56%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q1	dei	Amendment Flag AmendmentFlag	false
CY2014Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2014Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2014Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
CY2014Q1	dei	Document Period End Date DocumentPeriodEndDate	2014-03-31
CY2014Q1	dei	Document Type DocumentType	10-Q
CY2014Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001476963
CY2014Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6452341	shares
CY2013	htbx	Stock Issued During Period Value Conversion Of Shares Transaction One StockIssuedDuringPeriodValueConversionOfSharesTransactionOne		USD
CY2013	htbx	Stock Issued During Period Value Conversion Of Shares Transaction Three StockIssuedDuringPeriodValueConversionOfSharesTransactionThree		USD
CY2013	htbx	Stock Issued During Period Value Conversion Of Shares Transaction Two StockIssuedDuringPeriodValueConversionOfSharesTransactionTwo		USD
CY2014Q1	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2014Q1	dei	Entity Registrant Name EntityRegistrantName	HEAT BIOLOGICS, INC.
CY2014Q1	htbx	Amortization On Bond Premium AmortizationOnBondPremium	64935	USD
CY2013Q1	htbx	Amortization On Bond Premium AmortizationOnBondPremium		USD
	htbx	Amortization On Bond Premium AmortizationOnBondPremium	115716	USD
CY2014Q1	htbx	Cancellation Of Common Stock CancellationOfCommonStock		USD
CY2013Q1	htbx	Cancellation Of Common Stock CancellationOfCommonStock		USD
	htbx	Cancellation Of Common Stock CancellationOfCommonStock	65	USD
CY2014Q1	htbx	Cashless Exercise Of Stock Warrants CashlessExerciseOfStockWarrants	143190	USD
CY2013Q1	htbx	Cashless Exercise Of Stock Warrants CashlessExerciseOfStockWarrants		USD
	htbx	Cashless Exercise Of Stock Warrants CashlessExerciseOfStockWarrants	143190	USD
CY2014Q1	htbx	Clinical And Regulatory Expense ClinicalAndRegulatoryExpense	846384	USD
CY2013Q1	htbx	Clinical And Regulatory Expense ClinicalAndRegulatoryExpense	62057	USD
	htbx	Clinical And Regulatory Expense ClinicalAndRegulatoryExpense	2671384	USD
CY2014Q1	htbx	Conversion Of Convertible Note Payable To Accounts Payable ConversionOfConvertibleNotePayableToAccountsPayable		USD
CY2013Q1	htbx	Conversion Of Convertible Note Payable To Accounts Payable ConversionOfConvertibleNotePayableToAccountsPayable		USD
	htbx	Conversion Of Convertible Note Payable To Accounts Payable ConversionOfConvertibleNotePayableToAccountsPayable	197099	USD
CY2014Q1	htbx	Increase Decrease In Stock Subscription Receivable IncreaseDecreaseInStockSubscriptionReceivable		USD
CY2013Q1	htbx	Increase Decrease In Stock Subscription Receivable IncreaseDecreaseInStockSubscriptionReceivable	35000	USD
	htbx	Increase Decrease In Stock Subscription Receivable IncreaseDecreaseInStockSubscriptionReceivable		USD
CY2014Q1	htbx	Issuance Of Preferred Stock Warrants Including Debt Issuance Costs IssuanceOfPreferredStockWarrantsIncludingDebtIssuanceCosts		USD
CY2013Q1	htbx	Issuance Of Preferred Stock Warrants Including Debt Issuance Costs IssuanceOfPreferredStockWarrantsIncludingDebtIssuanceCosts		USD
	htbx	Issuance Of Preferred Stock Warrants Including Debt Issuance Costs IssuanceOfPreferredStockWarrantsIncludingDebtIssuanceCosts	87570	USD
CY2014Q1	htbx	Noncash Consideration For Rent NoncashConsiderationForRent		USD
CY2013Q1	htbx	Noncash Consideration For Rent NoncashConsiderationForRent		USD
	htbx	Noncash Consideration For Rent NoncashConsiderationForRent	15624	USD
CY2014Q1	htbx	Non Cash Conversion Of Preferred Stock Into Common Stock NonCashConversionOfPreferredStockIntoCommonStock		USD
CY2013Q1	htbx	Non Cash Conversion Of Preferred Stock Into Common Stock NonCashConversionOfPreferredStockIntoCommonStock		USD
	htbx	Non Cash Conversion Of Preferred Stock Into Common Stock NonCashConversionOfPreferredStockIntoCommonStock	386	USD
CY2014Q1	htbx	Noncash Investing And Financing Activities Beneficial Conversion Charge NoncashInvestingAndFinancingActivitiesBeneficialConversionCharge		USD
CY2013Q1	htbx	Noncash Investing And Financing Activities Beneficial Conversion Charge NoncashInvestingAndFinancingActivitiesBeneficialConversionCharge		USD
	htbx	Noncash Investing And Financing Activities Beneficial Conversion Charge NoncashInvestingAndFinancingActivitiesBeneficialConversionCharge	2300000	USD
CY2014Q1	htbx	Notes Payable Converted To Seriesa Preferred Stock NotesPayableConvertedToSeriesaPreferredStock		USD
CY2013Q1	htbx	Notes Payable Converted To Seriesa Preferred Stock NotesPayableConvertedToSeriesaPreferredStock		USD
	htbx	Notes Payable Converted To Seriesa Preferred Stock NotesPayableConvertedToSeriesaPreferredStock	2674980	USD
CY2009	htbx	Preferred Stock Issued During Period Value Issued For Cash PreferredStockIssuedDuringPeriodValueIssuedForCash	250000	USD
CY2011	htbx	Preferred Stock Issued During Period Value Issued For Cash PreferredStockIssuedDuringPeriodValueIssuedForCash	154255	USD
CY2012	htbx	Preferred Stock Issued During Period Value Issued For Cash PreferredStockIssuedDuringPeriodValueIssuedForCash	100000	USD
CY2013	htbx	Preferred Stock Issued During Period Value Issued For Cash PreferredStockIssuedDuringPeriodValueIssuedForCash	5050090	USD
CY2012	htbx	Preferred Stock Issued During Period Value Issued For Cash Transaction Three PreferredStockIssuedDuringPeriodValueIssuedForCashTransactionThree	900000	USD
CY2012	htbx	Preferred Stock Issued During Period Value Issued For Cash Transaction Two PreferredStockIssuedDuringPeriodValueIssuedForCashTransactionTwo	83334	USD
	htbx	Stock Issued During Period Value Issued For Cash Transaction Three StockIssuedDuringPeriodValueIssuedForCashTransactionThree	42	USD
CY2009	htbx	Stock Issued During Period Value Issued For Cash Transaction Three StockIssuedDuringPeriodValueIssuedForCashTransactionThree	23	USD
	htbx	Stock Issued During Period Value Issued For Cash Transaction Two StockIssuedDuringPeriodValueIssuedForCashTransactionTwo	60	USD
CY2009	htbx	Stock Issued During Period Value Issued For Cash Transaction Two StockIssuedDuringPeriodValueIssuedForCashTransactionTwo	5	USD
CY2012	htbx	Stock Issued During Period Value Issued For Cash Transaction Two StockIssuedDuringPeriodValueIssuedForCashTransactionTwo	10500	USD
CY2014Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	378399	USD
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	651917	USD
CY2014Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	378471	USD
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	503050	USD
CY2014Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	127298	USD
CY2013Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	106462	USD
CY2014Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	34686606	USD
CY2013Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	34337591	USD
CY2014Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	169112	USD
CY2009	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	13364	USD
CY2010	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	30791	USD
CY2011	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	91984	USD
CY2012	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	217896	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	571924	USD
CY2010	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	7584	USD
CY2011	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	17581	USD
CY2012	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	22419	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	944478	USD
CY2014Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	143190	USD
CY2014Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts		USD
CY2013Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	729	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	126742	USD
CY2014Q1	us-gaap	Assets Assets	20400078	USD
CY2013Q4	us-gaap	Assets Assets	23020066	USD
CY2014Q1	us-gaap	Assets Current AssetsCurrent	20332768	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	22955741	USD
CY2014Q1	us-gaap	Depreciation Depreciation	2170	USD
CY2013Q1	us-gaap	Depreciation Depreciation	814	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2690251	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4566992	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5030	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4889723	USD
CY2008Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue		USD
CY2014Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1876741	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	4884693	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	2690251	USD
CY2014Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0002
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0002
CY2014Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2014Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6452341	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6375426	shares
CY2014Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6452341	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6375426	shares
CY2014Q1	us-gaap	Common Stock Value CommonStockValue	975	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	961	USD
CY2013Q3	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	1696683	shares
CY2014Q1	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature		USD
CY2013Q1	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	-2300000	USD
	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	-2300000	USD
CY2014Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	9320	USD
CY2013Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	9320	USD
	us-gaap	Depreciation Depreciation	11728	USD
CY2014Q1	us-gaap	Development Stage Enterprise Deficit Accumulated During Development Stage DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage	14677227	USD
CY2013Q4	us-gaap	Development Stage Enterprise Deficit Accumulated During Development Stage DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage	12346630	USD
CY2014Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock		USD
CY2013Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock		USD
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	361668	USD
CY2014Q1	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	30092	USD
CY2013Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	24946	USD
CY2014Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.36
CY2013Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.66
CY2014Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	189673	USD
CY2013Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	356588	USD
CY2014Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P18M
CY2014Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	1777326	USD
CY2013Q3	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	10
CY2013Q3	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	10
CY2013Q3	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	10
CY2014Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	20600	USD
CY2013Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-14850	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	55620	USD
CY2014Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	20600	USD
CY2014Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	-143190	USD
CY2014Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue		USD
CY2013Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	122590	USD
CY2014Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1014870	USD
CY2013Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	268136	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5740192	USD
CY2014Q1	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	16749543	USD
CY2013Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	17297165	USD
CY2014Q1	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash		USD
CY2013Q1	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	1	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	1252	USD
CY2014Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	10975	USD
CY2013Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	1	USD
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	21730	USD
CY2014Q1	us-gaap	Interest Expense InterestExpense		USD
CY2013Q1	us-gaap	Interest Expense InterestExpense	28342	USD
	us-gaap	Interest Expense InterestExpense	298580	USD
CY2014Q1	us-gaap	Interest Paid InterestPaid		USD
CY2013Q1	us-gaap	Interest Paid InterestPaid	5593	USD
	us-gaap	Interest Paid InterestPaid	135606	USD
CY2014Q1	us-gaap	Interest Payable Current InterestPayableCurrent		USD
CY2013Q4	us-gaap	Interest Payable Current InterestPayableCurrent	25364	USD
CY2014Q1	us-gaap	Liabilities Liabilities	756870	USD
CY2013Q4	us-gaap	Liabilities Liabilities	1302921	USD
CY2014Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20400078	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23020066	USD
CY2014Q1	us-gaap	Liabilities Current LiabilitiesCurrent	756870	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1180331	USD
CY2014Q1	us-gaap	Minority Interest MinorityInterest	-367146	USD
CY2013Q4	us-gaap	Minority Interest MinorityInterest	-274777	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	36727	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5388776	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	33343255	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	477532	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16933725	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2391000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-504083	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13719279	USD
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	-2330597	USD
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	-3063856	USD
	us-gaap	Net Income Loss NetIncomeLoss	-17338895	USD
CY2014Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-92369	USD
CY2013Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-24605	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-367146	USD
CY2013Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	10362	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-24014	USD
CY2014Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		USD
CY2013Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	129321	USD
CY2014Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-28084	USD
CY2013Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-17979	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-300864	USD
CY2014Q1	us-gaap	Operating Expenses OperatingExpenses	2394882	USD
CY2013Q1	us-gaap	Operating Expenses OperatingExpenses	770482	USD
	us-gaap	Operating Expenses OperatingExpenses	15040374	USD
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2394882	USD
CY2013Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-770482	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-14454785	USD
CY2014Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	45000	USD
CY2013Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	40000	USD
CY2014Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10572	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10572	USD
CY2014Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent		USD
CY2013Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	122590	USD
CY2014Q1	us-gaap	Other Noncash Expense OtherNoncashExpense		USD
CY2013Q1	us-gaap	Other Noncash Expense OtherNoncashExpense		USD
	us-gaap	Other Noncash Expense OtherNoncashExpense	15624	USD
CY2014Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-39059	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	992062	USD
CY2014Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5155	USD
CY2013Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	68466	USD
CY2014Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments		USD
CY2013Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments		USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	17347946	USD
CY2014Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact		USD
CY2013Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact		USD
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	361668	USD
CY2014Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	862882	USD
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1066638	USD
CY2014Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		USD
CY2013Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	268007	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	2781636	USD
CY2014Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		USD
CY2013Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		USD
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	25110000	USD
CY2013Q3	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	25000000	USD
CY2013Q3	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	1000000	USD
CY2013Q3	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	1000000	USD
CY2013Q3	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	27000000	USD
CY2014Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		USD
CY2013Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	12330	USD
CY2014Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit		USD
CY2013Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit		USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	273427	USD
CY2014Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		USD
CY2013Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	200000	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1150000	USD
CY2014Q1	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments	482687	USD
CY2013Q1	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments		USD
	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments	482687	USD
CY2014Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	36727	USD
CY2013Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	90771	USD
CY2014Q1	us-gaap	Profit Loss ProfitLoss	-2422966	USD
CY2013Q1	us-gaap	Profit Loss ProfitLoss	-788461	USD
	us-gaap	Profit Loss ProfitLoss	-15044373	USD
	us-gaap	Profit Loss ProfitLoss	-281971	USD
CY2009	us-gaap	Profit Loss ProfitLoss	-423439	USD
CY2010	us-gaap	Profit Loss ProfitLoss	-721844	USD
CY2011	us-gaap	Profit Loss ProfitLoss	-2113142	USD
CY2012	us-gaap	Profit Loss ProfitLoss	-2471147	USD
CY2013	us-gaap	Profit Loss ProfitLoss	-6609864	USD
CY2014Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	56738	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	53753	USD
CY2014Q1	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		USD
CY2013Q1	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	197099	USD
CY2014Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit		USD
CY2013Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit		USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	273427	USD
CY2014Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		USD
CY2013Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1150000	USD
CY2014Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	533628	USD
CY2014Q1	us-gaap	Revenues Revenues		USD
CY2013Q1	us-gaap	Revenues Revenues		USD
	us-gaap	Revenues Revenues	585589	USD
CY2013Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	440289	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6628798	USD
CY2014Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1252	USD
CY2013Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1252	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-2422966	USD
CY2013Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-788461	USD
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-14755649	USD
CY2014Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax		USD
CY2013Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax		USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-288724	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-273518	USD
CY2013Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	356144	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	378399	USD
CY2014Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-124579	USD
CY2013Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	41107	USD
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	378471	USD
CY2014Q1	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits		USD
CY2013Q1	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits		USD
	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-9320	USD
CY2014Q1	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	5146	USD
CY2013Q1	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	-9571	USD
	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	30092	USD
CY2014Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-25364	USD
CY2013Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	18878	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	51269	USD
CY2014Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables		USD
CY2013Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	13009	USD
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables		USD
CY2014Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-203756	USD
CY2013Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	106798	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	862882	USD
CY2014Q1	us-gaap	Share Based Compensation ShareBasedCompensation	169112	USD
CY2013Q1	us-gaap	Share Based Compensation ShareBasedCompensation	26793	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1095071	USD
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2014Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y6M
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.1	pure
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0221	pure
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	379350	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.66
CY2014Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	22428	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.60
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	42964	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	7.90
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	599486	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	633482	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.02
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.36
CY2014Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y1M6D
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	379350	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	1.66
CY2014Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P6Y
CY2014Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.67
CY2014Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	7.90
CY2014Q1	us-gaap	Stockholders Equity StockholdersEquity	20010354	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	21991922	USD
CY2014Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	19643208	USD
CY2013Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	21717145	USD
CY2008Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-277444	USD
CY2009Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-431717	USD
CY2010Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1124594	USD
CY2011Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-334098	USD
CY2012Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1515109	USD
CY2013Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	21717145	USD
CY2008Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest		USD
CY2013Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	36167	shares
CY2014Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	54532	shares
CY2011	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		USD
	us-gaap	Stock Issued During Period Value Issued For Cash StockIssuedDuringPeriodValueIssuedForCash	321	USD
CY2009	us-gaap	Stock Issued During Period Value Issued For Cash StockIssuedDuringPeriodValueIssuedForCash	14	USD
CY2012	us-gaap	Stock Issued During Period Value Issued For Cash StockIssuedDuringPeriodValueIssuedForCash	825	USD
CY2013	us-gaap	Stock Issued During Period Value Issued For Cash StockIssuedDuringPeriodValueIssuedForCash	25110540	USD
	us-gaap	Stock Issued During Period Value Issued For Noncash Considerations StockIssuedDuringPeriodValueIssuedForNoncashConsiderations	4104	USD
CY2009	us-gaap	Stock Issued During Period Value Issued For Noncash Considerations StockIssuedDuringPeriodValueIssuedForNoncashConsiderations	5760	USD
CY2010	us-gaap	Stock Issued During Period Value Issued For Noncash Considerations StockIssuedDuringPeriodValueIssuedForNoncashConsiderations	5760	USD
CY2013Q2	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.4348	pure
CY2013Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	2500000	shares
CY2013Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	100000	shares
CY2013Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	100000	shares
CY2013Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	22400000	USD
CY2013Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	930000	USD
CY2013Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	930000	USD
CY2013Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	24300000	USD
CY2011	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	2674980	USD
CY2012	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		USD
CY2013	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		USD
CY2013	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend		USD
CY2014Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	36727	USD
CY2013	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	54042	USD
CY2009	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue		USD
CY2014Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	16500	USD
CY2013Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent		USD
CY2014Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	6412504	shares
CY2013Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	1859929	shares

Files In Submission

Name	View Source	Status
0001553350-14-000502-index-headers.html	Edgar Link	pending
0001553350-14-000502-index.html	Edgar Link	pending
0001553350-14-000502.txt	Edgar Link	pending
0001553350-14-000502-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
htbx-20140331.xml	Edgar Link	completed
htbx-20140331.xsd	Edgar Link	pending
htbx-20140331_cal.xml	Edgar Link	unprocessable
htbx-20140331_def.xml	Edgar Link	unprocessable
htbx-20140331_lab.xml	Edgar Link	unprocessable
htbx-20140331_pre.xml	Edgar Link	unprocessable
htbx_10q.htm	Edgar Link	pending
htbx_ex31z1.htm	Edgar Link	pending
htbx_ex31z2.htm	Edgar Link	pending
htbx_ex32z1.htm	Edgar Link	pending
htbx_ex32z2.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SCPX
Scorpius Holdings, Inc. Stock $scpx

2014 Q2 Form 10-Q Financial Statement

#000155335014000502 Filed on May 12, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCPX Scorpius Holdings, Inc. Stock $scpx

2014 Q2 Form 10-Q Financial Statement

#000155335014000502 Filed on May 12, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCPX
Scorpius Holdings, Inc. Stock $scpx